Edgewise Therapeutics director receives equity awards
Edgewise Therapeutics, Inc. director Edris Badreddin received new equity-based compensation.
Rhea-AI Filing Summary
Edgewise Therapeutics, Inc. director Edris Badreddin received new equity-based compensation. On June 5, 2026, he was granted stock options for 8,188 shares of common stock at an exercise price of $35.59 per share, expiring on June 5, 2036. He also received 5,619 Restricted Stock Units (RSUs). According to the terms, 100% of both the options and RSUs will vest on the earlier of June 5, 2027 or the business day prior to the 2027 annual meeting of stockholders. These are compensation grants, not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 13,807 shares
Grant/Award
2 txns
Insider
Edris Badreddin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 5,619 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 8,188 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 5,619 contracts (Direct);
Stock Option (Right to Buy) — 8,188 contracts (Direct)
Footnotes (2)
- F1. 100% of the Restricted Stock Units granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.
- F2. 100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.
Key Figures
Stock options granted: 8,188 options
Option exercise price: $35.59 per share
RSUs granted: 5,619 RSUs
+2 more
5 metrics
Stock options granted
8,188 options
Granted June 5, 2026 to director
Option exercise price
$35.59 per share
Stock Option (Right to Buy)
RSUs granted
5,619 RSUs
Granted June 5, 2026 to director
Option expiration date
June 5, 2036
Stock options awarded June 5, 2026
Vesting trigger date
June 5, 2027
Earlier of this date or business day before 2027 annual meeting
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, exercise price, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Restricted Stock Units financial
"security_title: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"conversion_or_exercise_price: 35.5900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-05T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vested financial
"100% of the Restricted Stock Units ... will become vested"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Edgewise Therapeutics (EWTX) director Edris Badreddin receive?
Director Edris Badreddin received stock options for 8,188 shares at a $35.59 exercise price and 5,619 Restricted Stock Units. Both awards are part of his director compensation and are tied to future vesting conditions.
When do EWTX director Edris Badreddin’s new stock options and RSUs vest?
All granted options and RSUs vest 100% on the earlier of June 5, 2027 or the business day before the 2027 annual stockholder meeting. This creates a single cliff-vesting date tied to time and the next annual meeting.
Are EWTX director Edris Badreddin’s Form 4 transactions open-market buys or sales?
The Form 4 shows grant or award acquisitions, not open-market trades. Badreddin received stock options and RSUs as compensation, with no shares bought or sold on the market in these reported transactions.
What are the terms of EWTX director Edris Badreddin’s new stock options?
The options cover 8,188 shares of Edgewise Therapeutics common stock at a $35.59 exercise price and expire on June 5, 2036. They vest in full on the earlier of June 5, 2027 or the business day before the 2027 annual meeting.
How many Restricted Stock Units did EWTX grant to director Edris Badreddin?
Edgewise Therapeutics granted 5,619 Restricted Stock Units to director Edris Badreddin. These RSUs convert into common shares upon vesting, which occurs on the earlier of June 5, 2027 or the business day prior to the 2027 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
